Health & Wellness - 2019 Archives

December 5, 2019
The company that makes aducanumab for Alzheimer's disease says that the drug slows mental decline. Biogen Inc. revealed its new analyses of data from its phase 3[...]

February 20, 2019

February 19, 2019

February 19, 2019

February 18, 2019

February 18, 2019

February 18, 2019

February 18, 2019

February 16, 2019

February 15, 2019
Explore more topics
Sign up

Mayo Clinic Connect
An online patient support community